Literature DB >> 20460404

Mechanisms of motility in metastasizing cells.

Mahmut Yilmaz1, Gerhard Christofori.   

Abstract

Cell migration and invasion are critical parameters in the metastatic dissemination of cancer cells and the formation of metastasis, the major cause of death in cancer patients. Migratory cancer cells undergo dramatic molecular and cellular changes by remodeling their cell-cell and cell-matrix adhesion and their actin cytoskeleton, molecular processes that involve the activity of various signaling networks. Although in the past years, we have substantially expanded our knowledge on the cellular and molecular processes underlying cell migration and invasion in experimental systems, we still lack a clear understanding of how cancer cells disseminate in metastatic cancer patients. Different types of cancer cell migration seem to exist, including single-cell mesenchymal or amoeboid migration and collective cell migration. In most epithelial cancers, loss of the cell-cell adhesion molecule E-cadherin and gain of mesenchymal markers and promigratory signals underlie the conversion of epithelial, differentiated cells to mesenchymal, migratory, and invasive cells, a process referred to as the epithelial-to-mesenchymal transition. Although solitary migrating epithelial cancer cells have mostly undergone epithelial-to-mesenchymal transition (mesenchymal migration), and sometimes even lose their cell-matrix adhesion (amoeboid migration), collective migration of cancer cells in cell sheets, clusters, or streams is also frequently observed. The molecular mechanisms defining the different modes of cancer cell migration remain in most parts to be delineated. (c)2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 20460404     DOI: 10.1158/1541-7786.MCR-10-0139

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  197 in total

Review 1.  Shielding the messenger (RNA): microRNA-based anticancer therapies.

Authors:  Elena Sotillo; Andrei Thomas-Tikhonenko
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

2.  Nanog and Oct4 overexpression increases motility and transmigration of melanoma cells.

Authors:  Aurelie Borrull; Stephanie Ghislin; Frederique Deshayes; Jessica Lauriol; Catherine Alcaide-Loridan; Sandrine Middendorp
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-11       Impact factor: 4.553

3.  Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway.

Authors:  Wei Li; Jiguang Ma; Qingyong Ma; Bin Li; Liang Han; Jiangbo Liu; Qinhong Xu; Wanxing Duan; Shuo Yu; Fengfei Wang; Erxi Wu
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 4.  Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes.

Authors:  Valentina R Minciacchi; Michael R Freeman; Dolores Di Vizio
Journal:  Semin Cell Dev Biol       Date:  2015-02-23       Impact factor: 7.727

5.  Shape in migration: quantitative image analysis of migrating chemoresistant HCT-8 colon cancer cells.

Authors:  Alessia Pasqualato; Vittorio Lei; Alessandra Cucina; Simona Dinicola; Fabrizio D'Anselmi; Sara Proietti; Maria Grazia Masiello; Alessandro Palombo; Mariano Bizzarri
Journal:  Cell Adh Migr       Date:  2013-10-22       Impact factor: 3.405

6.  MYLK promotes hepatocellular carcinoma progression through regulating cytoskeleton to enhance epithelial-mesenchymal transition.

Authors:  Jie Lin; Yihui He; Lingfeng Chen; Xiaoyan Chen; Shengbing Zang; Wansong Lin
Journal:  Clin Exp Med       Date:  2018-05-31       Impact factor: 3.984

Review 7.  Cell motility in cancer invasion and metastasis: insights from simple model organisms.

Authors:  Christina H Stuelten; Carole A Parent; Denise J Montell
Journal:  Nat Rev Cancer       Date:  2018-03-16       Impact factor: 60.716

8.  Acquisition of Cancer Stem Cell-like Properties in Human Small Airway Epithelial Cells after a Long-term Exposure to Carbon Nanomaterials.

Authors:  Chayanin Kiratipaiboon; Todd A Stueckle; Rajib Ghosh; Liying W Rojanasakul; Yi Charlie Chen; Cerasela Zoica Dinu; Yon Rojanasakul
Journal:  Environ Sci Nano       Date:  2019-05-24

9.  Fusarisetin A: Scalable Total Synthesis and Related Studies.

Authors:  Jing Xu; Eduardo J E Caro-Diaz; Michelle H Lacoske; Chao-I Hung; Colin Jamora; Emmanuel A Theodorakis
Journal:  Chem Sci       Date:  2012-08-23       Impact factor: 9.825

10.  Aberrant BAF57 signaling facilitates prometastatic phenotypes.

Authors:  Sucharitha Balasubramaniam; Clay E S Comstock; Adam Ertel; Kwang Won Jeong; Michael R Stallcup; Sankar Addya; Peter A McCue; William F Ostrander; Michael A Augello; Karen E Knudsen
Journal:  Clin Cancer Res       Date:  2013-03-14       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.